Genotype-phenotype analysis in HbS-beta-thalassemia

Human Heredity

Volumn 47, Issue 3, 1997, Pages 161-164

  Altay, C ^a   Oner C ^a   Oner R ^a   Mesci, L ^a   Balkan, H ^a   Gumruk F ^a   Gurgey A ^a   Tuzmen S ^b   Basak A N ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b BOGAZICI UNIVERSITY   (Turkey)

Author keywords

Beta thalassemia mutations; Sickle cell; Sickle cell beta thalassemia

Indexed keywords

BETA GLOBIN; HEMOGLOBIN F; HEMOGLOBIN S;

ADULT; AGE; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; MALE; PHENOTYPE;

EID: 1842293417     PISSN: 00015652     EISSN: 14230062     Source Type: Journal    
DOI: 10.1159/000154404     Document Type: Article

References (14)

1. Gonzalez-Redondo JM, Kutlar A, Kutlar F, McKic VC, Baysal E, Huisnian THJ: Molecular characterization of HbSC β-thalassemia in American Blacks. Am. J Hematol 1991:38:9-14.
2. Dimovskv V, Baysal E, Schiliro G, Dibenedetto SP, Huisman THJ: A mild type of HbS-β* thalassemia -92 C-T in a Sicilian family. Am J Hematol 1993:42:225-226.
3. Powars DR, Meiselman HJ, Fischer TC, Hiti A, Johnson C: Beta S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia: Use in prcdieting clinical severity. Am J Pediatr Hematol Oncol 1994:16: 55-61.
4. Alouch JR, Kiliny Y, Yuregir G, Bakioglu I, Kutlar A, Kutlar F, Huisman THJ: Sickle cell anemia among Eti-Turks: Hematological, clinical and genetic observations. Scand J Hematol 1986:64:45-55.
5. Altay C, Basak AN: Molecular basis and prenatal diagnosis of hemoglobinopathies in Turkey. Int J Pediatr Hematol Oncol 1995:2:283-290.
6. Betke K, Marti HR, Schtichl I: Estimation of small percentages of foetal hemoglobin. Nature 1959; 184: 1877-1878.
7. Huisman THJ, Jonxis JHP: The Hemoglobinopathies. Techniques of Identification: Clinical and Biochemical Analysis. New York, Marcel Dekker. 1977. vol 6.
8. Old JM, Varawalla N, Weatherall DJ: Rapid detection and prenatal diagnosis of beta thalassemia: Studies in Indian and Cypriot populations in the UK. Lancet 1990,336: 834-836.
9. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain terminating inhibitors. Proe Na:l Acad Sci USA 1977:74:5463-5469.
10. Wave JS, Cliui DHK, Eng B, Cai SP, Coleman MB, Adams JG III. Steinberg MH: HbS/β* thalassemia due to 1.4 kb deletion is associated with a relatively mild phenotype. Am J Hematol 1991;38:108-112.
11. Perscu L, Ristaldi MS. Dibencdetto SP, Testa R. Schiliro G. Pirastu M. Cao A: The effect of β thalassemia mutation on the clinical severity of the sickle cell β thalassemia syndrome. Hacmatologica 1989:74: 341-345.
12. Galanello R: Molecular basis of thalassemia major. Int J Pediatr Hematol Oncol 1995:2:383-390.
13. Giirgcy A, Altay C, Diaz-C’hico JC, Kutlar F, Kutlar A, Huisman THJ: Molecular heterogeneity of beta thalassemia intermedia in Turkey. Acta Haematol 1989:81:22-27.
14. Loukopoulos D: The HbS syndromes in the Mediterranean basin: A review. Hematol Rev 1992:6:69-75.